...
机译:试行的评估成本效用的贝伐单抗和化疗和化疗在先进的非小细胞肺癌
Fred Hutchinson Cancer Research Center, Seattle, WA, United States, University of Washington;
Bevacizumab; Drug Therapy; Antineoplastic AgentsNon-Small-Cell Lung CarcinomaQuality-Adjusted Life YearsCost EffectivenessLung;
机译:The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials
机译:Switch maintenance treatment with oral vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer: a phase II study
机译:Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer
机译:Stereotactic Ablative Radiotherapy versus Lobectomy for Operable Stage I Non-small-cell Lung Cancer: A Pooled Analysis of Two Randomized Trials——胸外科医生的解读
机译:iaspp is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway